Author:
Hoshika Yu,Kubota Yoshiaki,Mozawa Kosuke,Tara Shuhei,Tokita Yukichi,Yodogawa Kenji,Iwasaki Yu-Ki,Yamamoto Takeshi,Takano Hitoshi,Tsukada Yayoi,Asai Kuniya,Miyamoto Masaaki,Miyauchi Yasushi,Kodani Eitaro,Maruyama Mitsunori,Tanabe Jun,Shimizu Wataru
Funder
Boehringer Ingelheim
Boehringer Ingelheim Foundation
Eli Lilly and Company
Subject
Cardiology and Cardiovascular Medicine
Reference30 articles.
1. Age-specific trends in the incidence and in-hospital mortality of acute myocardial infarction over 30 years in Japan — report from the Miyagi AMI Registry Study;Cui;Circ J,2017
2. Clinical potential of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes;Kim;Diabetes Metab Syndr Obes,2012
3. Dapagliflozin in patients with heart failure and reduced ejection fraction;McMurray;N Engl J Med,2019
4. Cardiovascular and renal outcomes with empagliflozin in heart failure;Packer;N Engl J Med,2020
5. Using dilution techniques and multifrequency bioelectrical impedance to assess both total body water and extracellular water at baseline and during recombinant human growth hormone (gh) treatment in gh-deficient adults*;Janssen;J Clin Endocrinol Metab,1997
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献